The UAE intragastric
balloons market is anticipated to observe an impressive growth during the
forecast period, 2023-2027. The major factors include increasing
prevalence of obesity, technological advancements, and customer preference for non-surgical and
non-invasive procedures. An intragastric balloon is a saline- filled or
gas-filled balloon that is placed inside the stomach for losing weight. It is
inserted orally to restrict the amount of food stored by the stomach, thereby
providing an early feeling of satiety. It also aids in eliminating the other
health related concerns such as strokes, diabetes, and high blood pressure. Various
advancements are done for optimal results and the reduction of associated
difficulties. The other factor which are bolstering the market growth are changing lifestyle, increasing investments on healthcare
sector, growing awareness and low price of
intragastric balloon procedure.
Increasing Prevalence of
Obesity
The increasing
prevalence of obesity is one of the main reasons to drive the growth of the
market. Owing to lack of inactiveness, deskbound jobs, alcohol consumptions and
unhealthy eating habits, a significant portion of the world's population is
suffering from weight-related health concerns. Thus, many physicians’ advice
patients to lose weight due to which overweight and obese people opt for
intragastric balloons method, as it serves as an effective non-surgical
procedure. As per the Central Intelligence Agency World Factbook, the UAE
has an obesity prevalence rate of 31.7%.
Preference Towards
Non-Surgical and Non-Invasive Procedures
Nowadays, due to
increase in awareness among masses regarding the weight-loss procedures, obese
and overweight adults prefer non-surgical and non-invasive treatments,
including intragastric balloons. Intragastric balloons serves as an effective
non-surgical substitute for weight-loss as they are inserted orally and do not
require any incisions on the body. Also, it has fast recovery rate with less
discomfort. Likewise, growing preference for non- invasive surgeries are
bolstering the market growth.
Technological
Advancements
Technological
advancements and product innovations are the key factor influencing the market.
Manufacturers are focusing on creating product variants with minimal
side-effects, such as gastric erosion, ulceration, and nausea. The advancements
are done in intragastric balloons, by coupling dual and triple balloons to
prevent the migration of device from stomach to intestine, thus, in turn reduce
the risk intestinal obstruction. They are also designing balloons with
adjustable gas/saline volumes. In UAE, allurion Technologies announced the
availability of its Gastric Balloon technology, for people with age between 16
to 65 years in selected clinics, it is the first and only weight loss tool in
the world without surgery, endoscopy, or anesthesia.
Download Free Sample Report
Market
Segmentation
The UAE Intragastric
balloons market is segmented into
administration, balloon type, filling
type, application, end user,
and company. Based on administration, the market is divided
into pill form and endoscopy. Based on balloon type, the market is
divided into single, dual, and triple. Based on filling type, the
market is divided into saline filled and gas filled. Based on application, the market is divided into obesity, diabetes, diet control, and others. Based
on end user, the market is divided into hospitals
& clinics, ambulatory surgical centers, and others. In terms of region, the market is segmented
into Abu Dhabi, Dubai, Sharjah, and Rest of UAE.
Market
Players
Obalon Therapeutics, Inc. (UAE), Allurion
Technologies, Inc. (UAE), ReShape Lifesciences Inc (UAE), Silimed Inc. (UAE), Allergan
Middle East Limited, Vasmed UAE, and Life Mate Medical Equipment Trading LLC are some of the leading companies
operating in the market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, Volume Units and CAGR for 2017-2021
and 2022-2027
|
|
Report coverage
|
Revenue forecast, Volume forecast company share, competitive
landscape, growth factors, and trends
|
|
Segments covered
|
·
Product
·
Application
·
End User
·
Company
|
|
Regional scope
|
Abu Dhabi; Dubai; Sharjah;
and Rest of UAE
|
|
Key companies profiled
|
Obalon Therapeutics, Inc. (UAE), Allurion Technologies, Inc.
(UAE), ReShape Lifesciences Inc (UAE), Silimed Inc. (UAE), Allergan Middle
East Limited, Vasmed UAE, and Life Mate Medical Equipment Trading LLC
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, UAE intragastric
balloons market has been segmented into following categories, in addition to
the industry trends which have also been detailed below:
·
UAE Intragastric balloons
Market, By Administration:
·
UAE Intragastric Balloons Market, By Balloon Type:
o
Single
o
Dual
o
Triple
·
UAE Intragastric balloons Market, By Filling Type:
·
UAE Intragastric balloons
Market, By Application:
- Obesity
- Diabetes
- Diet Control
- Others
·
UAE Intragastric balloons
Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
·
UAE Intragastric balloons
Market, By Region:
o
Abu
Dhabi
o
Dubai
o
Sharjah
o
Rest
of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major
companies present in Intragastric balloons market
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of additional market players (up to
five).
Intragastric Balloons
Market is an upcoming report to
be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at [email protected]